Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas

NMR in Biomedicine

Volumn 23, Issue 2, 2010, Pages 179-187

  Kwee, Thomas C ^a   Galbán, Craig J ^a   Tsien, Christina ^a   Junck, Larry ^a   Sundgren, Pia C ^a   Ivancevic, Marko K ^a,b   Johnson, Timothy D ^a   Meyer, Charles R ^a   Rehemtulla, Alnawaz ^a   Ross, Brian D ^a   Chenevert, Thomas L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

Brain tumor; Diffusion weighted magnetic resonance imaging; Glioma; Intravoxel water diffusion heterogeneity; Stretched exponential

Indexed keywords

BASAL GANGLIA; BRAIN STRUCTURE; BRAIN TUMORS; CORTICAL GREY MATTER; DIFFUSION COEFFICIENTS; DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING; EXPONENTIAL MODELS; GREY MATTERS; HETEROGENEITY INDEX; HIGH-GRADE GLIOMAS; NEGATIVE CORRELATION; PEARSON CORRELATION COEFFICIENTS; PEARSON'S CORRELATION COEFFICIENTS; POTENTIAL VALUES; T-TESTS; WATER DIFFUSION; WHITE MATTER;

CORRELATION METHODS; DIFFUSION IN LIQUIDS; IMAGE SEGMENTATION; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; ONCOLOGY;

TUMORS;

ADULT; AGED; ARTICLE; BASAL GANGLION; CANCER GRADING; CLINICAL ARTICLE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GLIOMA; GRAY MATTER; HUMAN; IMAGING; MALE; PRIORITY JOURNAL; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; BRAIN MAPPING; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; TEMPORAL LOBE; WATER; YOUNG ADULT;

EID: 77149153402     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1441     Document Type: Article

References (21)

1. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet. 2003; 361: 323-331.
2. Reardon DA, Rich JN, Friedman HS, Bigner DD. Recent advances in the treatment of malignant astrocytoma. J. Clin. Oncol. 2006; 24: 1253-1265.
3. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiol. 2006; 239: 632-649.
4. Hamstra DA, Galbán CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, Lawrence TS, Junck L, Ross DJ, Rehemtulla A, Ross BD, Chenevert TL. Functional diffusion map as an early imaging biomarker for highgrade glioma: correlation with conventional radiologic response and overall survival. J. Clin. Oncol. 2008; 26: 3387-3394.
5. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J. Clin. Oncol. 2007; 25: 4104-4109.
6. Maier SE, Bogner P, Bajzik G, Mamata H, Mamata Y, Repa I, Jolesz FA, Mulkern RV. Normal brain and brain tumor: multicomponent apparent diffusion coefficient line scan imaging. Radiol. 2001; 219: 842-849.
7. Bennett KM, Schmainda KM, Bennett RT, Rowe DB, Lu H, Hyde JS. Characterization of continuously distributed cortical water diffusion rates with a stretched-exponential model. Magn. Reson. Med. 2003; 50: 727-734.
8. Lee JH, Springer CS Jr. Effects of equilibrium exchange on diffusionweighted NMR signals: the diffusigraphic 'shutter-speed'. Magn. Reson. Med. 2003; 49: 450-458.
9. Bennett KM, Hyde JS, Rand SD, Bennett R, Krouwer HG, Rebro KJ, Schmainda KM. Intravoxel distribution of DWI decay rates reveals C6 glioma invasion in rat brain. Magn. Reson. Med. 2004; 52: 994-1004.
10. Bennett KM, Hyde JS, Schmainda KM. Water diffusion heterogeneity index in the human brain is insensitive to the orientation of applied magnetic field gradients. Magn. Reson. Med. 2006; 56: 235-239.
11. Kleihues P, Cavanee WK. World Health Organization Classification of Tumors. Pathology and Genetics. Tumours of the Nervous System. International Agency for Research on Cancer Press: Lyon, 2000.
12. Johnson PC, Hunt SJ, Drayer BP. Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiol. 1989; 170: 211-217.
13. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, Chang S, Dillon WP, Nelson SJ. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J. Magn. Reson. Imag. 2004; 19: 546-554.
14. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J. Clin. Oncol. 1990; 8: 1277-1280.
15. Dempsey F, Condon BR, Hadley DM. Measurement of tumor 'size' in recurrent malignant glioma: 1D, 2D, or 3D? A.J.N.R. Am. J. Neuroradiol. 2005; 26: 770-776.
16. Palumbo B. Brain tumour recurrence: brain single-photon emission computerized tomography, PET and proton magnetic resonance spectroscopy. Nucl. Med. Commun. 2008; 29: 730-735.
17. Poustchi-Amin M, Mirowitz SA, Brown JJ, McKinstry RC, Li T. Principles and applications of echo-planar imaging: a review for the general radiologist. Radiograph. 2001; 21: 767-779.
18. Glockner JF, Hu HH, Stanley DW, Angelos L, King K. Parallel MR imaging: a user's guide. Radiograph. 2005; 25: 1279-1297.
19. Maier SE, Mamata H, Mulkern RV. Characterization of normal brain and brain tumor pathology by chisquares parameter maps of diffusion-weighted image data. Eur. J. Radiol. 2003; 45: 199-207.
20. Hall MG, Barrick TR. From diffusion-weighted MRI to anomalous diffusion imaging. Magn. Reson. Med. 2008; 59: 447-455.
21. Jensen JL, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusion kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn. Reson. Med. 2005; 53: 1432-1440.